Demethylating agent 5-aza-2′-deoxycytidine activates HLA-G expression in human leukemia cell lines

被引：25

作者：

Polakova, K. ^{[2
]}

Bandzuchova, E. ^{[3
]}

Kuba, D. ^{[3
]}

Russ, G. ^{[1
]}

机构：

[1] Slovak Acad Sci, Inst Virol, Bratislava 84505, Slovakia

[2] Slovak Acad Sci, Canc Res Inst, Bratislava 84505, Slovakia

[3] Slovak Med Univ, Bratislava, Slovakia

来源：

LEUKEMIA RESEARCH | 2009年 / 33卷 / 04期

关键词：

HLA-G; Leukemia cells; Demethylation; 5-Aza-2 '-deoxycytidine; CHRONIC LYMPHOCYTIC-LEUKEMIA; TUMOR-CELLS; G GENE; PROMOTER REGION; CANCER; DNA; DECITABINE; INHIBITORS; PROTEINS;

D O I：

10.1016/j.leukres.2008.08.003

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

HLA-G is a non-classical HLA class I antigen primarily expressed in the extravillous cytotrophoblast. HLA-G can also be expressed at some pathological circumstances and may thus contribute to inhibition of efficient immune responses. Complex regulation of HLA-G expression also involves epigenetic mechanisms as DNA methylation. Here we demonstrate that treatment with demethylating agent 5-aza-2'-deoxycytidine (AdC) resulted in HLA-G transcription in 18 out of 20 examined leukemia cell lines. FILA-G protein synthesis was detected in 10 cell lines expressing significant level of HLA-G transcripts following AdC treatment. (C) 2008 Elsevier Ltd. All rights reserved

引用

页码：518 / 524

页数：7

共 50 条

[11] 5-aza-2′-deoxycytidine, a DNA demethylating agent, inhibits metastatic melanoma invasiveness
Etievant, Chantal
Desjobert, Cecile
Carrier, Arnaud
Delmas, Audrey
Tost, Jorg
Favre, Gilles
Riond, Joelle
Arimondo, Paola
CANCER RESEARCH, 2014, 74 (19)
[12] Induction of MAGE genes in lymphoid cells by the demethylating agent 5-aza-2'-deoxycytidine
Shichijo, S
Yamada, A
Sagawa, K
Iwamoto, O
Sakata, M
Nagai, K
Itoh, K
JAPANESE JOURNAL OF CANCER RESEARCH, 1996, 87 (07): : 751 - 756
[13] 5-AZA-2′-deoxycytidine (5-AZA-CdR):: a demethylating agent affecting development and reproductive capacity
Cisneros, FJ
Branch, S
JOURNAL OF APPLIED TOXICOLOGY, 2003, 23 (02) : 115 - 120
[14] The in vivo induction of sister chromatid exchange by the demethylating agent 5-aza-2′-deoxycytidine
Rodriguez-Reyes, R.
Morales-Ramirez, P.
MUTAGENESIS, 2011, 26 (04) : 551 - 554
[15] Mechanisms of resistance to 5-aza-2′-deoxycytidine in human cancer cell lines
Qin, Taichun
Jelinek, Jaroslav
Si, Jiali
Shu, Jingmin
Issa, Jean-Pierre J.
BLOOD, 2009, 113 (03) : 659 - 667
[16] The hematopathological basis for studying effects of the demethylating agent 5-aza-2′-deoxycytidine (decitabine) in myelodysplasia
Schaefer, HE
Lübbert, M
ANNALS OF HEMATOLOGY, 2005, 84 (Suppl 1) : 67 - 79
[17] The hematopathological basis for studying effects of the demethylating agent 5-aza-2′-deoxycytidine (decitabine) in myelodysplasia
Hans Eckart Schaefer
Michael Lübbert
Annals of Hematology, 2005, 84 : 67 - 79
[18] Methylation status of genes upregulated by demethylating agent 5-aza-2′-deoxycytidine in hepatocellular carcinoma
Hirasawa, Yuichi
Arai, Makoto
Imazeki, Fumio
Tada, Motohisa
Mikata, Rintaro
Fukai, Kenichi
Miyazaki, Masaru
Ochiai, Takenori
Saisho, Hiromitsu
Yokosuka, Osamu
ONCOLOGY, 2006, 71 (1-2) : 77 - 85
[19] Retraction Note to: Induction of HLA-G expression in a melanoma cell line OCM-1A following the treatment with 5-aza-2'-deoxycytidine
Chien-Chung CHANG
Cell Research, 2005, 15 (8) : 678 - 678
[20] The hematopathological basis for studying effects of the demethylating agent 5-aza-2′-deoxycytidine (decitabine) in myelodysplasia
Hans Eckart Schaefer
Micheal Lübbert
Annals of Hematology, 2006, 85 (9) : 637 - 637

← 1 2 3 4 5 →